Volume replacement in critically ill patients with acute renal failure

Journal of the American Society of Nephrology

Volumn 12, Issue SUPPL. 17, 2001, Pages

  Ragaller, M J R ^a   Theilen, H ^a   Koch, T ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; DEXTRAN; HETASTARCH;

ACUTE KIDNEY FAILURE; ARTICLE; BLOOD CLOTTING; CAPILLARY PERMEABILITY; COLLOID; CRITICAL ILLNESS; CRYSTALLOID; HEMODYNAMICS; HUMAN; HYPOVOLEMIA; INTENSIVE CARE; KIDNEY FUNCTION; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; MICROCIRCULATION; MOLECULAR WEIGHT; OSMOTIC PRESSURE; PATIENT MONITORING; PLASMA VOLUME; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; RISK BENEFIT ANALYSIS; SAFETY;

EID: 0035140882     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals
2. Hypovolemic shock
3. Pathogenetic mechanisms of septic shock
4. Crystalloids versus colloids in the treatment of hypovolemic shock
5. Strategies of volume therapy in sepsis and systemic inflammatory response syndrome
6. Mechanisms and classification of shock
7. Sepsis/septic shock: Participation of the microcirculation: An abbreviated review
8. Cellular effectors of the septic process
9. Human albumine on the intensive care unit: Can we live without it
10. Acquired renal insufficiency in critically ill patients
11. Acute renal failure in sepsis and multiple organ failure
12. Adequate crystalloid resuscitation restores but fails to maintain the active hepatocellular function following hemorrhagic shock
13. Comparison of the effects of volume resuscitation with dextran 60 vs. Ringer's lactate on central hemodynamics, regional blood flow, pulmonary function, and blood composition during hyperdynamic endotoxemia
14. Crystalloids vs. colloids in fluid resuscitation: A systemic review
15. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: A systemic review of randomised trials
16. Volume replacement strategies on intensive care units: Results from a postal survey
17. Fluid therapy: Present controversies
18. Efficacy of albumin supplementation in the surgical intensive care unit: A prospective, randomized study
19. The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients
20. Human albumin administration in critically ill patients: Systematic review of randomised controlled trials
21. A paradigm for consensus: The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions
22. Gelatin impairs platelet adhesion during cardiac surgery
23. Reduced quality of clot formation with gelatin-based plasma substitutes
24. Anaphylactoid reactions to colloid plasma substitutes: Incidence, risk factors, mechanisms: A French multicenter prospective study
25. Toxic effects of colloids in the intensive care unit
26. The use of plasma substitutes with special attention to their side effects
27. Acute renal failure after administration of low-molecular weight dextran
28. Safety of dextran in relation to other colloids: Ten years experience with hapten inhibition
29. Renal failure after the administration of dextran 40
30. Adverse effects of colloids on renal function
31. Incidence of acute oligoanuric renal failure in dextran 40 treated patients with acute ischemic stroke stage ILL or IV
32. Fetal risks with dextrans during delivery
33. Impact of dextran on microvascular disturbances and tissue injury following ischemia/reperfusion in striated muscle
34. An international view of hydroxyethyl starches
35. All medium starches are not the same: Influence of the degree of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation
36. The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients
37. Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery
38. The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation: An in vitro study
39. Monocyte chemotaxis and chemotactic cytokine release after exposure to hydroxyethyl starch
40. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury
41. Pentafraction reduces the lung lymph response after endotoxin administration in the ovine model
42. Hydroxyethyl starch: Safe or not?
43. Hydroxyethylstarch administration does not depress reticuloendothelial function or increase mortality from sepsis
44. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation
45. Acute renal failure associated with elevated plasma oncotic pressure
46. A functional role for the tubuloglomerular feedback mechanism
47. Risk factors for acute postoperative renal failure in thoracic or thoracoabdominal aortic surgery: A prospective study
48. Large-dose administration of 6% hydroxyethyl starch 200/0.5 for total hip arthroplasty: Plasma homeostasis, hemostasis, and renal function compared to use of 5% human albumin
49. The influence of different intravascular volume replacement regimens on renal function in the elderly
50. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients
51. Hydroxyethylstarch and osmotic nephrosis-like lesions in kidney transplants
52. Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: A retrospective, multicentre analysis